The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study

Cited by (374)

Items 301–374 of 374

1. Differentially abundant transcripts in PBMC of hospitalized geriatric patients with hip fracture compared to healthy aged controls
   Thi Kim Duy Vo, Patrice Godard, Marie de Saint‐Hubert, Gabriel Morrhaye, Florence Debacq‐Chainiaux, Christian Swine, Vincent G. Geenen, Henri Martens, Olivier Toussaint · 2010 · Experimental Gerontology
2. Diagnosing and treating the elderly individual with hypopituitarism
   Andrea Corsello, Rosa Maria Paragliola, Roberto Salvatori · 2023 · Reviews in Endocrine and Metabolic Disorders
3. Therapeutic patents for chronic heart failure: a review of patent applications from 1996 to 2002
   Stefan D. Anker, Ewa Anita Jankowska, Darlington Obinnaya Okonko · 2004 · Expert Opinion on Therapeutic Patents
4. Endocrinology and Aging
   Steven W. J. Lamberts · 2011 · Elsevier eBooks
5. Growth Hormone
   Vivien S. Herman-Bonert, Shlomo K. Melmed · 2010 · Elsevier eBooks
6. IGF Signaling in the Heart in Health and Disease
   Daria A. Adasheva, Daria V. Serebryanaya · 2024 · Biochemistry (Moscow)
7. Arterial Aging: The Role of Hormonal and Metabolic Status and Telomere Biology
   Irina Dmitrievna Strazhesko, Daria A. Kashtanova, Е. N. Dudinskaya, Olga N. Tkacheva · 2019 · Healthy ageing and longevity
8. Preoperative Risk Stratification of Increased MIB-1 Labeling Index in Pituitary Adenoma: A Newly Proposed Prognostic Scoring System
   Ivan Maiseyeu, Ági Güresir, Hartmut Vatter, Ulrich Herrlinger, Albert J. Becker, Johannes Wach, Erdem Güresir · 2022 · Journal of Clinical Medicine
9. Bioavailable IGF-1 is beneficially associated with biomarkers of endothelial function in young healthy adults: The African-PREDICT study
   Sunelle A. Barnard, Wayne T Smith, Catharina M. C. Mels, Shani Botha‐Le Roux, Aletta Elisabeth Schutte · 2018 · Growth Hormone & IGF Research
10. IGF-1 is not related to long-term outcome in hyperglycemic acute coronary syndrome patients
    Cindya Perthy Iswandi, Victor J. van den Berg, Suat Şimşek, Daan M. van Velzen, Edwin ten Boekel, Jan Hein Cornel, Sanneke P.M. de Boer, Maarten de Mulder, K. Martijn Akkerhuis, Eric H. Boersma et al. · 2021 · Diabetes and Vascular Disease Research
11. An adjunctive preventive treatment for heart disease and a set of diagnostic tests to detect it: Insulin-like growth factor-1 deficiency and cell membrane pathology are an inevitable cause of heart disease
    Robert Eli, James A. Fasciano · 2006 · Medical Hypotheses
12. Declining Levels and Bioavailability of IGF-I in Cardiovascular Aging Associate With QT Prolongation–Results From the 1946 British Birth Cohort
    Christos Charalambous, James Moon, Jeff M.P. Holly, Nish Chaturvedi, Alun David Hughes, Gabriella Captur · 2022 · Frontiers in Cardiovascular Medicine
13. Hormonal Therapy in the Treatment of Chronic Heart Failure
    Raffaele Napoli, Andrea Salzano, Eduardo Bossone, Antonio Cittadini · 2017 · Elsevier eBooks
14. Effects of Pomegranate Extract on IGF-1 Levels and Telomere Length in Older Adults (55–70 Years): Findings from a Randomised Double-Blinded Controlled Trial
    Grace Farhat, Jhama Malla, Liam Hanson, Jay Vadher, Emad A. S. Al‐Dujaili · 2025 · Nutrients
15. IGF-1 downregulates matrix metalloproteinase 8 to promote plaque stability: Evidence from myeloid cell-specific MMP8 in atherosclerosis
    Patricia Snarski, Sergiy Sukhanov, Tadashi Yoshida, Svitlana D. Danchuk, Andrew Gross, Fareed Sindi, Vikara Rivera-Lopez, Patrice Delafontaine, Yusuke Higashi · 2025 · PLoS ONE
16. The Role of GH-IGF-1 Axis and S-Klotho in Atherosclerosis Natural History, Plaque Phenotype and Vulnerability: A Narrative Review
    Angela Buonpane, Salvatore Raia, Giancarlo Trimarchi, Donato Antonio Paglianiti, Fabio Casamassima, Giorgio Maria Orazi, Carlo Trani, F Crea, Giovanna Liuzzo, Francesco Burzotta et al. · 2026 · Biomedicines
17. Charting individualized pathways: IGF-1 and vitamin D in guiding personalized medicine for residual risk after AMI
    Aneta Aleksova, Milijana Janjusevic, Maria E. Marketou, Antonio Paolo Beltrami, Elena Dozio, Giulia Vanin, Lorenzo Zandonà, Andrea Chicco, Daria Beltrame, Francesco Perone et al. · 2026 · Progress in Cardiovascular Diseases
18. DO GROWTH HORMONE AND INSULIN-LIKE GROWTH FACTOR 1 AFFECT PROGNOSIS IN PATIENTS WITH KILLIP I AND II CLASS ACUTE MYOCARDIAL INFARCTION?
    Larisa Dizdarević‐Hudić · 2016 · Acta Clinica Croatica
19. Likely causal effects of insulin resistance and IGF-1 bioaction on childhood and adult adiposity: a Mendelian randomization study
    Duaa Ibrahim Olwi, Lena R Kaisinger, Katherine A. Kentistou, Marc Vaudel, Stasa Stankovic, Pål R. Njølstad, Stefan Johansson, John R. B. Perry, Felix R. Day, Ken K. Ong · 2024 · International Journal of Obesity
20. Therapeutic role of metformin and troglitazone to prevent cancer risk in diabetic patients: evidences from experimental studies
    Muhammad Ejaz ul Haq, Muhammad Sajid Hamid Akash, Kanwal Rehman, Mohsin Khurshid · 2020 · Turkish Journal of Biochemistry
21. Hormonal Changes During and After Cardiac Surgery
    Marcello Maggio, Chiara Cattabiani, Gian Paolo Ceda · 2011 · Springer eBooks
22. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study
    A.W. Meikle · 2008 · Yearbook of Endocrinology
23. Existe-t-il une relation entre la dose d'hormone de croissance et d'éventuelles complications tumorales ou cardiovasculaires ?
    Yves Le Bouc, Frédéric Brioude · 2012 · Bulletin de l Académie Nationale de Médecine
24. Growth hormone in heart failure revisited: An old story retold
    Antonio Cittadini, Roberta D’Assante · 2018 · Monaldi Archives for Chest Disease
25. Endothelial dysfunction in patients with acromegaly and It's association with Endocan
    Şeref Kul, Özge Telci Çaklılı, Yasemin Tütüncü, Fatma Betül Özcan, Feyza Aksu, Ömer Faruk Baycan, Adem Atıcı, Ümmühan Zeynep BİLGİLİ, Mümtaz Takır, Mustafa Çalışkan · 2020 · Growth Hormone & IGF Research
26. The effect of hormone therapy on surrogate measures of cardiovascular disease
    Clarisa R. Gracia, Steven J. Sondheimer · 2008 · Menopause The Journal of The North American Menopause Society
27. Issues in Long-Term Management of Adults with Growth Hormone Deficiency
    Anne McGowan, James Gibney · 2011 · Humana Press eBooks
28. Associations of coefficient of variation of serum GH with previous radiotherapy, hypopituitarism and cardiac disease in patients with treated acromegaly
    Channa Nalin Jayasena, Chioma N. Izzi‐Engbeaya, Shakunthala Narayanaswamy, Manish Modi, Holly Clarke, Gurjinder M. K. Nijher, Karim M. Meeran, Waljit Singh Dhillo · 2014 · Clinical Endocrinology
29. IGF-1 and IGFBP-3 Levels in Individuals with Varied Kidney Function and the Relation to Dietary Protein Intake
    Megan Kh Sankey · 2009 · OhioLink ETD Center (Ohio Library and Information Network)
30. OBSOLETE: Hormonal Therapy for Heart Failure
    Antonio Cittadini · 2017 · Elsevier eBooks
31. The Multiple Actions of the Insulin-Like Growth Factor-I Signaling in the Myocardium
    Αnastassios Philippou, Maria D. Maridaki, Theodore Karatzas, Michael Koutsilieris · 2014 · Springer eBooks
32. Anabolic Deficiencies in Heart Failure
    Raffaele Napoli, Roberta D’Assante, Martina Miniero, Andrea Salzano, Antonio Cittadini · 2022 · Cardiology Clinics
33. Can signal peptide-CUB-EGF domain-containing protein 1 (SCUBE-1) be used as an indicator of endothelial dysfunction in acromegaly patients?
    Damla Tüfekçı̇, İrfan Nuhoğlu, Sumeyye Sura Ayan, Yasemin Günay, Hülya Coşkun, Muhammet Cüneyt Bilginer, Özge Üçüncü, Mustafa Koçak, Serap Özer Yaman, Süleyman Caner Karahan · 2023 · Endocrine
34. IGF-I; IGF-binding protein-3 and breast cancer risk
    Andrew G. Renehan, Marcel Zwahlen, Matthias Egger, Stephen Michael Shalet · 2005 · Breast Cancer Online
35. Insulin-Like Growth Factors, Cardiovascular Risk Factors, and Cardiovascular Disease
    Islam A. Bolad, Patrice Delafontaine · 2008 · Humana Press eBooks
36. Manipulation of the insulin-like growth factor 1 receptor on the vascular endothelium : the effect on whole body and endothelial specific insulin sensitivity
    V Kate Gatenby · 2014 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
37. Tratamento com hormônio de crescimento (GH) em crianças com deficiência de GH: importância das dosagens de IGF-I e IGFBP3 na individualização da dose de GH
    Frederico Guimarães Marchisotti · 2007
38. Associations between cellular growth factors and ischemic and hemorrhagic strokes
    Yukihiko Momiyama · 2012 · Atherosclerosis
39. P-77 Relationships between serum insulin-like growth factor-I levels, blood pressure and glucose tolerance: an observational, exploratory study in 404 subjects
    Annamaria Colao, Carolina Di Somma, Teresa Cascella, Rosario Pivonello, Giovanni Vitale, Lucia Grasso, Gaetano Lombardi, Silvia Savastano · 2008 · Growth Hormone & IGF Research
40. Uptodate on GH/IGF-1 axis actions
    R Baldelli · 2013 · Reviews in Endocrinology and Metabolism
41. IGF-1: Analytik und Referenzbereiche / Measurement of IGF-1 and reference ranges
    Elisabeth Spilcke-Liss, Nele Friedrich, Henri Wallaschofski · 2008 · Journal of Laboratory Medicine
42. INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS-1 AND -3 AND SEX HORMONE-BINDING GLOBULIN: STUDIES ON REGULATION OF SYNTHESIS IN VITRO, AND CLINICAL ASPECTS
    Tarja Kalme · 2005
43. Mechano-Growth Factor in the Failing Heart
    Gerard Patrick Devlin · 2011 · ResearchSpace (University of Auckland)
44. som för avläggande av medicine doktorsexamen vid Karolinska Institutet offentligen försvaras i Thorax Aula, Karolinska Universitetssjukhuset i Solna, fredagen den 13 februari 2009 klockan 9.00 av
    Märit Wallander · 2009
45. The Relation Between IGF-1, GH, IGFBP3 Levels and Stroke and Comorbid Disease
    Akinci · 2012 · Turkish Journal of Emergency Medicine
46. Hormony a układ sercowo-naczyniowy Hormones and the cardiovascular system
    Katarzyna Łącka · 2008
47. Growth hormone axis in patients with ST elevation myocardial infarction and non-ST elevation myocardial infarction
    Larisa Dizdarević‐Hudić, Zumreta Kušljugić, Fahir Baraković, Mithad Hajder, Maida Isabegović, Igor Hudić, Elnur Smajić, Ivana Iveljić · 2013 · Cardiovascular Endocrinology
48. The Yin and Yang of IGF-1 and Ghrelin
    ROSS G. CLARK · 2005 · CRC Press eBooks
49. GENETIC VARIATION AT THE INSULIN-LIKE GROWTH FACTOR 1 GENE AND ASSOCIATION WITH BREAST CANCER, BREAST DENSITY AND ANTHROPOMETRIC MEASURES
    Gordon Fehringer · 2008 · TSpace (University of Toronto)
50. Estudio de envejecimiento de Mataró: Factores hormonales y genéticos que influyen en el envejecimiento
    Mireia Mora · 2015 · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
51. Changes in Acid Labile Subunit (ALS) and Insulin-Like Growth Factor 1 (IGF-1) Concentration in Hyperthyroidism before and After Medical Treatment: A Prospective Controlled Study
    Kamal A.S. Al-Shoumer · 2017 · Endocrinology&Metabolism International Journal
52. Physical Activity, Aerobic Fitness, and Insulin-Like Growth Factor-1 in Individuals with Acute Stroke
    Anna E. Mattlage · 2016 · KU ScholarWorks (The University of Kansas)
53. Insulin-Like Peptides Regulate Plasmodium falciparum Infection in Anopheles stephensi
    Jose E. Pietri, Shirley Luckhart · 2017 · Elsevier eBooks
54. Links between insulin resistance, inflammation and subclinical macrovascular disease in type 2 diabetes
    Eeva S. Leinonen · 2005 · Työväentutkimus Vuosikirja
55. Relationship of IGF-1 and CKMB in Ischemic heart disease subjects
    Saima Sharif, Muhammad Saqib, Shagufta Naz, Misbah Manzoor, Afshan Kaleem, Mehwish Iqtedar · 2018 · Endocrinology&Metabolism International Journal
56. FRI0030 FEELINGS OF GUILT AND SHAME IN PATIENTS WITH RHEUMATOID ARTHRITIS
    B. A. Hiba, Alia Fazaa, S. Miladi, Kmar Ouenniche, Leila Souabni, Selma Kassab, Selma Chekili, Leïth Zakraoui, K. Ben Abdelghani, A. Laatar · 2019 · Annals of the Rheumatic Diseases
57. Role Of Insulin Like Growth Factor-1 and Insulin Like Growth Factor Binding Protein-3 In Patients Of Coronary Artery Disease Attending Suez Canal University Hospital
    Emad F. Ismail, Amany Y. Elkazaz, Ahmed Taher El-Serafi, May Abd El All, Gamela Mohamed Nasr · 2012 · Bulletin of Egyptian Society for Physiological Sciences
58. Does insulin-like growth factor influence prognosis ten months after myocardial infarction?
    Yücel Yılmaz, Mustafa Duran, Mustafa Altay, Eyüp Özkan, Fatih Tanrıverdi, Namık Kemal Eryol · 2020 · Ortadoğu Tıp Dergisi
59. IGF-1 as a Target in Emerging Heart Failure Therapeutics
    Paulina Joanna Ramos · 2018 · UA Campus Repository (The University of Arizona)
60. Efeitos vasculometabólicos em pacientes adultos com hipopituitarismo congênito com e sem terapia com hormônio do crescimento
    Isabela Peixoto Biscotto · 2020
61. The Yin and Yang of IGF-1 and Ghrelin
    ROSS G. CLARK · 2005 · CRC Press eBooks
62. The Association between Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 Levels and Clinical Prognosis in Patients with Ischemic Stroke
    Hasan Yaşar, Temel Tombul, Aysel Milanlıoğlu · 2015 · Turkish Journal of Cerebrovascular Diseases
63. Minimizing Cardiometabolic Risk Factors in Patients with Acromegaly
    Divya Yogi-Morren, Laurence Kennedy · 2022 · Springer eBooks
64. Leukocyte Telomere Length and Neuregulin-4 Levels in Female Patients with Acromegaly: The Relationship between Disease Activity and Body Fat Distribution
    Meriç Coşkun, Alev Eroğlu Altınova, Afruz Babayeva, Aydın Tuncer Sel, Dilek Yapar, Mine Karaca, Mehmet Muhittin Yalçın, Müjde Aktürk, Füsun Baloş Törüner, Mehmet Ayhan Karakoç et al. · 2023 · Journal of Clinical Medicine
65. Levels of parathyroid hormone and IGF binding protein 1 and associations with mortality and hip fractures in older women
    Elin Uzunel, Hans Ranch Lundin, Ann-Charlotte Grahn Kronhed, Per Erik Wändell, Helena Salminen · 2024 · Scientific Reports
66. Case Report: Efficacy and safety of recombinant growth hormone therapy in a girl with Loeys–Dietz syndrome
    Kamil Dyrka, Aleksander Jamsheer, Michał Bartecki, Waldemar Bobkowski, Małgorzata Pawelec-Wojtalik, Justyna Rajewska-Tabor, Andzelika Tomaszewska, Justyna Balcerzak, Zuzanna Aniol, Marek Niedziela et al. · 2025 · Frontiers in Cardiovascular Medicine
67. Urine and Serum Biomarkers of Cardiovascular Status and Early Vascular Ageing in Children and Adults
    Mikaela Frixou, Catherine C. Fraser, Angela Katrina Lucas-Herald · 2025 · Artery Research
68. Inverse association of insulin-like growth factor binding protein 1 with epicardial and intrathoracic adiposity in older adults: The Longenity study
    Rohan A. Kankaria, Joseph Nicholas Charla, Kenny Q. Ye, Leandro N. Slipczuk, Damini Dey, Jeffrey M. Levsky, Wanda Guzman, Daniel Amadeo, Aribah Zaidi, Jorge R. Kizer et al. · 2026 · Diabetes Research and Clinical Practice
69. A one-week reduced-carbohydrate diet lowers insulin requirements and shifts the IGF axis with no detectable short-term change in endothelial function in a randomized, crossover trial of adults with type 1 diabetes
    M. Naweed Akbar, T. Jordan Smith, Sivaprakasam Chinnarasu, Wendi Welch, Wang Zuofei, Bridget Litts, Lauren M. LeStourgeon, Mohammad Saleem, Mohd Mabood Khan, Annet Kirabo et al. · 2026 · Cardiovascular Diabetology – Endocrinology Reports
70. Evaluation of the Relationship Between Insulin-like Growth Factor-1 Levels, Systemic Immune-Inflammatory Markers, and Metabolic Comorbidities in Patients with Obesity
    Gökhan Rıza Baykal, M Keskin, Belma Özlem Tural Balsak, Çağlar Keskin, Didem Özdemir, Oya Topaloğlu, REYHAN ERSOY, Bekir Çakır · 2026 · Bariatric Surgical Practice and Patient Care
71. Discordant associations of IGF-binding proteins 1 & 2 with diabetes and cardiovascular disease: insights from UK Biobank
    Emily R Rolfe-Hammerton, Marcella S Conning-Rowland, Lia E. De Faveri, Katie J. Simmons, Paul J. Meakin, Richard M. Cubbon, Stephen Bentley Wheatcroft · 2026 · medRxiv
72. Associations of cognitive reserve with IGF-1 and global cognition differ by early-life conditions and APOE genotype
    Sayonara Pereira da Silva, Charikleia Lampraki, Stéphane Cullati, Tainá S. Rêgo, Paolo Ghisletta, Matthias Kliegel, Jürgen Maurer, Matthias Studer, Élvio Rúbio Gouveia, Marcelo de Maio Nascimento et al. · 2026 · Experimental Gerontology
73. Isoflavone effects on insulin like growth factors and breast cancer.
    Maeli J. Campbell · 2008 · UCL Discovery (University College London)
74. Bassi livelli di IGF-I sono associati ad aumentata mortalità per cardiopatia ischemica
    Gail A. Laughlin, Elizabeth L. Barrett-Connor, Michael H. Criqui, Donna C. Kritz‐Silverstein, Annamaria Colao, Maria Cristina De Martino · 2004 · L Endocrinologo